DENND1C Activators
DENND1C Activators encompass a range of chemical compounds that indirectly enhance the functional activity of DENND1C, a protein involved in the regulation of vesicular trafficking and membrane dynamics. Specifically, Forskolin, by increasing cAMP levels, activates PKA, which is known to influence the recruitment of Rab GTPases, a process central to DENND1C's role in cellular trafficking. Sphingosine-1-phosphate, via G protein-coupled receptor signaling, potentially augments DENND1C-mediated endosomal transport by modulating the cellular signaling milieu to favor DENND1C's activity. Thapsigargin and A23187, by increasing intracellular calcium, can enhance DENND1C's interaction with Rab GTPases due to the critical role of calcium in vesicular fusion and trafficking. PMA, as a PKC activator, and kinase inhibitors like Staurosporine and EGCG, may skew cellular signaling pathways to enhance DENND1C's role in trafficking by altering the membrane recruitment of Rab GTPases or by inhibiting kinases that negatively regulate DENND1C's function.
U0126 and SB203580, inhibitors of the MEK and p38 MAPK pathways, respectively, may also boost DENND1C activity by reducing competing signaling activities that affect DENND1C's role in vesicular formation and trafficking. The compounds listed differ widely in their primary targets and mechanisms of action, yet they all have the potential to indirectly promote DENND1C's role in vesicular trafficking, which is crucial for the proper functioning of cellular processes such as protein sorting, receptor recycling, and signal transduction.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin directly stimulates adenylate cyclase, increasing intracellular cAMP levels. Elevated cAMP activates PKA, which could enhance DENND1C's role in modulating vesicular trafficking by promoting the recruitment of Rab proteins to specific membranes where DENND1C functions. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
This lipid signaling molecule binds to its G protein-coupled receptors, which could indirectly result in the activation of DENND1C by altering cytoskeletal dynamics and membrane trafficking events, thereby facilitating DENND1C's role in vesicular transport. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin causes an increase in cytosolic calcium levels by inhibiting the sarco/endoplasmic reticulum Ca2+-ATPase (SERCA). The resultant calcium signaling may enhance DENND1C-mediated signaling by promoting its interaction with Rab GTPases involved in membrane trafficking. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
As a PKC activator, PMA can alter intracellular signaling pathways. This modulation could indirectly enhance DENND1C's functional activity in vesicular trafficking by affecting the membrane recruitment of Rab GTPases, which are central to DENND1C's role. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
By inhibiting p38 MAPK, SB203580 could promote DENND1C activity by reducing the competitive influence of p38 MAPK on DENND1C-associated signaling pathways, particularly those related to vesicular formation and trafficking. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 increases intracellular calcium levels, which may indirectly enhance DENND1C's role in vesicular trafficking and protein sorting by affecting the calcium-dependent signaling pathways that influence these processes. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Although a broad-spectrum kinase inhibitor, staurosporine might selectively enhance DENND1C's pathways by inhibiting kinases that negatively regulate DENND1C's role in vesicular trafficking, thus promoting DENND1C's function in this capacity. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is a broad-spectrum kinase inhibitor that could enhance DENND1C's function by inhibiting kinases that compete with or negatively regulate DENND1C's role in vesicular trafficking processes. | ||||||